Výsledky vyhledávání - "Yann, Quentric"

Report of the TFOS/ARVO Symposium on Global Treatments for Dry Eye Disease: An Unmet Need

Autor: Per Gjorstrup, Benjamin Sullivan, Stefano Barabino, Yann Quentric, Carolyn G. Begley, Masatsugu Nakamura, Jean-Sebastien Garrigue, David A. Sullivan, Gary D. Novack, Debra A. Schaumberg, Michelle Dalton, Katherine M. Hammitt

Publikováno v: The Ocular Surface. 10:108-116

In September 2010, a Symposium in Florence, Italy, was held to address the unmet need for global treatments for dry eye disease (DED). It was sponsored by The Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and co-sponsored by the Associa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dc1a7bffb6a8c7e0a2248decce391635
https://doi.org/10.1016/j.jtos.2012.02.001

Zobrazit plný text záznamu

An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT 2C receptor-mediated [ 3 H]phosphatidylinositol depletion

Autor: Didier Cussac, Yann Quentric, Adrian Newman-Tancredi, Mark Millan

Publikováno v: Naunyn-Schmiedeberg's Archives of Pharmacology. 361:221-223

6-chloro-5-methyl-1-[6-(2-methylpyridin-3-yloxy) pyridin-3-ylcarbamoyl] indoline (SB242,084) is a novel, selective 5-HT(2C) receptor antagonist, but its actions at these sites have been little characterised at the cellular level. We employed a rapid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a53bd0b8fdc32383745e890943aa7b96
https://doi.org/10.1007/s002109900178

Zobrazit plný text záznamu

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes

Autor: Millan Mark, Adrian Newman-Tancredi, Laurence Verrièle, Yann Quentric, Manuelle Touzard, Nathalie Carpentier, Didier Cussac

Publikováno v: The Journal of pharmacology and experimental therapeutics. 303(2)

Although certain antiparkinson agents interact with serotonin (5-HT) receptors, little information is available concerning functional actions. Herein, we characterized efficacies of apomorphine, bromocriptine, cabergoline, lisuride, piribedil, pergol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db302430684a95660d7b0bfeaf0d26a8
https://pubmed.ncbi.nlm.nih.gov/12388668

Zobrazit plný text záznamu

The 'selective' dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors

Autor: Didier Cussac, Millan Mark, Adrian Newman-Tancredi, Yann Quentric

Publikováno v: Psychopharmacology. 156(1)

Rationale: The benzazepine and "selective" dopamine D1 receptor antagonist, SCH23390 [(R)-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-benzazepine-7-ol], shows significant affinity at native serotonin (5-HT)2C receptors. Objectives: We examin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e188f91720bc583d9e27a6bacdf473c
https://pubmed.ncbi.nlm.nih.gov/11465634

Zobrazit plný text záznamu

Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols

Autor: Adrian Newman-Tancredi, Millan Mark, Guillaume Poissonnet, Solo Goldstein, Yann Quentric, Nathalie Carpentier, Jean-Gilles Parmentier, Didier Cussac

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology. 365(3)

Employing a novel, rapid and sensitive method for evaluation of phospholipase C (PLC) activity, the present study characterized the actions of diverse agonists and antagonists at human (h)5-HT2C receptors expressed in Chinese Hamster Ovary (CHO) cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e520544a1188978d532eb827db882576
https://pubmed.ncbi.nlm.nih.gov/11882920

Zobrazit plný text záznamu